Gnosis Launches EdenDx, the First Non-Invasive Liquid-Based Cytology U.S. Test for Early Endometrial Cancer Detection

Gnosis, a Southern California-based diagnostic lab advancing women's health through molecular innovation, today announced the national launch of EdenDx, which stands for Early Detection for Endometrial Neoplasia, the first commercially available non-invasive liquid-based cytology test in the United States for early-stage endometrial cancer detection. Endometrial cancer is the fourth most common cancer among women in […]

CPI Aerostructures Receives Follow-on Orders Totaling $2.4 Million for Welded Assemblies

(NYSE MKT:CVU), EDGEWOOD, N.Y., July 30, 2025 (GLOBE NEWSWIRE) — CPI Aerostructures, Inc. (“CPI Aero(R)” or the “Company”) (NYSE American: CVU) today announced that it has received follow-on orders from multiple existing customers totaling $2.4 million to weld complex structural assemblies used on a U.S. military helicopter. Deliveries are expected to occur through mid-2026. “CPI

LENZ Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

(NASDAQ:LENZ), New Drug Application (NDA) for LNZ100 for treatment of presbyopia on track for PDUFA target action date of August 8, 2025 88-member sales force hired and prepared to initiate sales and marketing activities immediately upon approval Executed multiple international license and commercialization agreements for LNZ100 including over $195 million in upfront and milestone payments

Corbus Pharmaceuticals Announces Upcoming Presentation of Dose Expansion Phase 1/2 Clinical Data for its Nectin-4 Targeting ADC CRB-701 at the 2025 ESMO Annual Congress

(NASDAQ:CRBP), NORWOOD, Mass., July 30, 2025 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, announced today that an abstract on updated clinical data from its Phase 1/2 clinical study conducted in the United States and Europe of CRB-701 (SYS6002) has been accepted for presentation as a

Kane Biotech Showcases revyve(TM) Preclinical and Clinical Case Study Findings at North American Wound Care Conferences

(TSX-V:KNE),(OTC US:KNBIF),(Other OTC:KNBIF), Clinical case series showed clinically meaningful reductions in wound size and pain, and improved tissue regranulation in chronic wound patients using revyve(R) over 6-12 weeks Preclinical in vitro studies demonstrated >80% reduction in protease activity, including complete inhibition of TACE and collagenase — key factors in non-healing chronic wounds revyve(R) data featured

Leopardo Energy, Town of Speedway announce utility plant partnership

INDIANAPOLIS, July 30, 2025 (GLOBE NEWSWIRE) — Leopardo Energy, in partnership with the Town of Speedway, has announced a biogas treatment system that will capture methane gas and convert it into energy at the local Speedway utility plant located at 4251 W. Vermont Street. Generating both electricity and heat from a single fuel source, Combined

GraniteShares launches new YieldBoost ETFs on COIN (COYY)

New York, NY, July 30, 2025 (GLOBE NEWSWIRE) — GraniteShares, an ETF issuer specializing in high conviction ETFs, announced that it is launching one ETFs to add to its existing YieldBOOST lineup – the GraniteShares YieldBOOST COIN ETF (COYY). The GraniteShares YieldBOOST COIN ETF (COYY) is designed to generate income from options1 strategies linked to

Cloudbrink Adds Native Identity Management and Crowdstrike Integration to its SASE, Creating a Unified Platform with Higher Security and Less Complexity

SUNNYVALE, Calif., July 30, 2025 (GLOBE NEWSWIRE) — Cloudbrink, a leader in high-performance secure connectivity, today introduced a suite of identity management services and an integration with Crowdstrike to its Personal SASE platform. Combined, these services allow customers to manage both the authentication and authorization of users from one single console with a unified policy

Shiplify Revolutionizing Revenue Retention Through Accessorial Identification Technology

ATLANTA, July 30, 2025 (GLOBE NEWSWIRE) — Shiplify, the primary accessorial revenue identifier for carriers, shippers and third-party logistics (3PL) providers, today introduced the first of its kind accessorial ROI calculator. This tool brings unprecedented upfront visibility into freight invoicing for shippers, carriers and third-party logistics (3PL) providers. With increasing pressure on margins and relationships

ZOIA Healthcare Acquires Lil’s Dietary to Expand Commitment to Rare Metabolic Disease Community

Boothwyn, PA., July 30, 2025 (GLOBE NEWSWIRE) — ZOIA Healthcare, Inc. (ZOIA), a Pentec Company, is pleased to announce its acquisition of Lil'S Low Carb Inc. (Lil's Dietary), a boutique provider of medical and low-protein foods specializing in the needs of individuals with inborn errors of metabolism. With more than 20 years of dedicated service,

Scroll to Top